Lin BioScience, Inc. (6696)
TWSE
Closed
Aug 24, 2026
Day's Range
93.7052 wk Range
14.90Overview - 6696 - Lin BioScience, Inc.
Key Statistics
Valuation
Enterprise Value
76.27B
Price / Book
‪7.34‬
EV / EBITDA
‪-19.28‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Return on Assets
‪-15.72%‬
Return on Equity
‪-21.83%‬
Ownership
Shares Outstanding
82.82M
Float
64.89M
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.13%‬
Price stats
50-Day Avg
‪63.93‬
200-Day Avg
‪45.41‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 6696 - Lin BioScience, Inc.
Peers - 6696 - Lin BioScience, Inc.
Peer Comparison
Compared with companies in Biotechnology listed on TWSE.
- 6696TWSELin BioScience, Inc.77.69BMarket Cap+83.89%52-week change—P/E (Trailing)‪0.00%‬Profit Margin
- 6949TWSEPell Bio-Med Technology Co., Ltd.80.61BMarket Cap+68.42%52-week change-170.12P/E (Trailing)‪-13.97%‬Profit Margin
- 6919TWSECaliway Biopharmaceuticals Co., Ltd.42.55BMarket Cap—52-week change-155.08P/E (Trailing)‪70.55%‬Profit Margin
- 6586TWSECho Pharma Inc.24.18BMarket Cap+66.02%52-week change—P/E (Trailing)‪74.49%‬Profit Margin
- 4743TWSEOneness Biotech Co., Ltd.23.97BMarket Cap-48.00%52-week change384.62P/E (Trailing)‪39.54%‬Profit Margin
- 4728TWSESunmax Biotechnology Co., Ltd.21.54BMarket Cap-4.17%52-week change29.76P/E (Trailing)‪35.54%‬Profit Margin
- 7827TWSEHanchorBio Inc.19.68BMarket Cap+42.70%52-week change—P/E (Trailing)‪-159.37%‬Profit Margin
Profile Summary - 6696 - Lin BioScience, Inc.
About
Lin BioScience, Inc. is a clinical-stage biotechnology company headquartered in Taipei, Taiwan, focused on the research and development of innovative pharmaceuticals that address diseases with significant unmet medical needs. Founded in 2016, the company operates primarily within the healthcare sector, targeting areas…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
